Nasal Vaccines: Global Market Scenario, Trends, Opportunity, Growth and Forecast, 2020-2030

Market Definition

A nasal vaccine is one that promotes an immune response without the need for an injection. It is given through the nose. Through the nose’s inner surface, which naturally comes into contact with various airborne bacteria, it promotes immunity. Because they don’t require needles and may be administered through the mucosal route, nasal vaccinations are becoming more and more popular as alternatives to injectable vaccines.

 Market Insights

Compared to routine immunisations, nasal vaccines have a few advantages. The medical field requires noninvasive, less expensive substitutes for injectable vaccines in the current Covid wave crisis caused by new versions. Nasal vaccinations accomplish both goals since they do away with the need for needles, which lowers the price of vaccines and makes mass vaccination easier. They could also improve syringe-phobic people’s willingness to comply with immunisation requirements. The potential of needle contamination is eliminated with nasal vaccines because they can be administered as a spray. Since they require less complex storage conditions than the cold storage facilities needed for intramuscular vaccines, they are more affordable for low- and middle-income countries. Additionally, because they stimulate the formation of antibodies in the airway passageways, nasal vaccinations are more effective against respiratory viruses. Finally, self-administration of nasal vaccinations eases some of the burden on busy medical practitioners. Nasal vaccinations are the greatest choice for quickly mutating viruses like SARS-CoV-2 because their spike proteins can simply be altered to combat new strains of a virus.

Nasal vaccines are in higher demand as a result of the COVID-19 epidemic. Leading vaccine makers see nasal vaccines as a potential source of future profits. This is attributable to a rise in regulatory and governmental backing, which has also sped up the creation of potent intramuscular COVID vaccines. The development of nasal vaccines that can be administered as sprays or drops into the nose and provide additional protection by promoting mucosal immunity has been encouraged by the emergence of coronavirus variants that can evade the immune response elicited by existing vaccines.

The biggest regional market for nasal vaccines is in Europe. With a market share of $250 million in 2022 and a projected increase to $330 million over the course of the projection period at a CAGR of 9.3%, Europe accounted for 55% of the global market for nasal vaccines. Major factors driving the expansion of the nasal vaccine market in Europe include the presence of large vaccine producers like AstraZeneca, Sanofi, and GlaxoSmithKline, as well as a highly supportive research environment, numerous academic organizations, a strong regulatory framework, and well-implemented immunisation programmes.

Market Dynamics: Drivers

Rising Incidence of Respiratory Infections

Nasal vaccine demand has increased as a result of the current coronavirus pandemic, as well as rising rates of swine flu, respiratory syncytial virus (RSV) infections, influenza, pneumonia, and other respiratory illnesses. According to data from the WHO, respiratory infections are responsible for 6% of all diseases worldwide. 95% of the 6.6 million children under the age of five who die as a result of these diseases live in low- to middle-income countries. Furthermore, 20% to 40% of hospital hospitalisations and 20% to 30% of paediatric intensive care unit (ICU) admissions for children under the age of five are attributable to respiratory infections.

Cost-Effective Alternative to Mainstream Vaccines

Nasal vaccines’ improved R&D has demonstrated how affordable they are in comparison to other widely used vaccines. Nasal vaccines cost less to administer in large groups than injections with needles. These vaccines can be kept in refrigerators, which is a cost-effective storage option that is crucial for low- and middle-income nations.

Market Dynamics: Challenges

Technical Drawbacks of Nasal Vaccines

Nasal vaccination technical difficulties are a significant barrier to this market’s expansion. In order to successfully transfer the antigens to the antigen-presenting cells (APCs) in the respiratory tract during the manufacture of a nasal vaccination, nasal clearance must be overcome. The epithelial layer traps the virus particles, which are then expelled from the body. Because of this, the type of antigen used in vaccine formulation should allow it to stay in the respiratory system for long enough to allow for antigen absorption and trigger an immune response.

Market Segmentation

• Based on Type, the Global Nasal Vaccines market is segmented into
  • Live-Attenuated Vaccines
  • Inactivated Vaccines
  • Viral Vector Vaccines
  • Protein Subunit Vaccines
• Based on Dosage Form, the Global Nasal Vaccines market is segmented into
  • Nasal Sprays
  • Nasal Drops
  • Nasal Powders
  • Nasal Gels
• Based on Patient Group, the Global Nasal Vaccines market is segmented into
  • Paediatric
  • Adult
• Based on End User, the Global Nasal Vaccines market is segmented into
  • Primary Care Clinics
  • Hospitals
  • Pharmacies
  • Others
• Based on Geography, the Global Nasal Vaccines market is segmented into
  • Asia-Pacific
  • North America
  • Europe
  • Latin America
  • Middle East & Africa

• All market revenue has been given in US Dollar.

Historical Year: 2020-2021
Base Year: 2022
Estimated: 2023
Forecast- 2024-2030

Key Questions this Study will Answer

• What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Market Size-By Volume, Forecast Numbers, Market Segmentation, Market Shares) of Global Nasal Vaccines Market?
• What is the region wise industry size, growth drivers and challenges key market trends?
• What are the key innovations, opportunities, current and future trends and regulations in the Global Nasal Vaccines Market?
• Who are the key competitors, what are their key strength and weakness and how they perform in Global Nasal Vaccines Market based on competitive benchmarking matrix?
• What are the key results derived from the market surveys conducted during Global Nasal Vaccines Market study?